Call Our HELPLINE: 1-800-4PD-INFO (473-4636)

Parkinson’s Foundation Adds Alison Herman to its Board of Directors

MIAMI – May 9, 2018 – The Parkinson’s Foundation today announced the election of Alison Herman to its board of directors. Herman is senior counsel at Southern Glazer’s Wine & Spirits, a company which has generously supported Parkinson’s Foundation fundraisers.

“Alison brings a proven ability to engage the philanthropic community of the Parkinson’s Foundation in funding research that helps improve the lives of people with the disease. I have known Alison for more than 30 years and am extremely impressed with her passion for our cause,” said John W. Kozyak, Esq., chairman of the board of the Parkinson’s Foundation. “We are proud to welcome Alison to our Board.”

Herman joined Southern Glazer’s in 2008 and currently focuses on regulatory and compliance matters in the 44 states where Southern Glazer’s operates. Prior to that, she served 14 years as attorney at Breier Seif Herman & Silverman, P.A., specializing in corporate acquisitions, retirement plans, distribution agreements, private foundations, tax and estate planning. Leveraging her experience, Herman has been instrumental in assisting the Parkinson’s Foundation Wines on the Bay event. Herman received a law degree from the University of Miami School of Law.

“It is an honor to join the Parkinson’s Foundation board and a great privilege to serve its community of those who are living with the disease,” Herman said. “Seeing a close family member affected by Parkinson’s gives me great resolve in the Foundation’s mission to make life better for people with Parkinson’s.”

A complete list of the Parkinson’s Foundation’s Board of Directors is available at www.parkinson.org/board.

###

About the Parkinson’s Foundation
The Parkinson’s Foundation makes life better for people with Parkinson’s disease by improving care and advancing research toward a cure. In everything we do, we build on the energy, experience and passion of our global Parkinson’s community. For more information, visit www.parkinson.org or call (800) 4PD-INFO (473-4636).

About Parkinson’s Disease
Affecting an estimated one million Americans and 10 million worldwide, Parkinson’s disease is the second-most common neurodegenerative disease after Alzheimer’s and is the 14th-leading cause of death in the United States. It is associated with a progressive loss of motor control (e.g., shaking or tremor at rest and lack of facial expression, as well as non-motor symptoms (e.g., depression and anxiety). There is no cure for Parkinson’s and 60,000 new cases are diagnosed each year in the United States alone.

 

Tuesday, May 8, 2018
Parkinson’s Foundation Announces First Aware in Care Ambassadors
Monday, February 25, 2019

NEW YORK & MIAMI — February 25, 2019 — The Parkinson’s Foundation today announced the first members of its Aware in Care Ambassador Pilot Program, a volunteer group organized to help distribute Aware in Care kits that serve to bolster best practices in treating patients with Parkinson’s disease to both patients and healthcare providers.

Parkinson’s Foundation Hosts Professional Education Training in Iowa City
Wednesday, February 13, 2019

Partnership with the University of Iowa Hospitals & Clinics

Breaking News: Boston Scientific: Boston Scientific Launches Vercise™ Primary Cell And Vercise Gevia™ Deep Brain Stimulation Systems With Directional Leads
Thursday, January 24, 2019

Parkinson's Foundation cited in Boston Scientific Press Release: MARLBOROUGH, Mass., Jan. 24, 2019  -- Boston Scientific Corporation (NYSE: BSX) has launched the Vercise™Primary Cell (PC) and Vercise Gevia™ Deep Brain Stimulation (DBS) Systems featuring the Vercise Cartesia™ Directional Lead. The new systems, which were recently approved by the U.S.

Parkinson's Foundation Announces State Level Prevalence Medicare Costs of Parkinson's Disease - Diagnosis of Parkinson’s Associated with Greater Spending
Thursday, January 24, 2019


NEW YORK & MIAMI, January 24, 2019—A Parkinson’s Foundation study recently published in the scientific journal, npj Parkinson’s Disease, found that a diagnosis of Parkinson’s disease (PD) was associated with greater healthcare use and spending.

Breaking News: FDA Approves Treatment for “Off” Periods in Parkinson’s
Thursday, December 27, 2018

The U.S. Food and Drug Administration (FDA) has approved INBRIJA™, a levodopa inhalation powder developed by Acorda Therapeutics, as a treatment for “off” periods in people with Parkinson’s disease (PD) who are treated with carbidopa/levodopa.

Quick Facts about INBRIJA™:

Parkinson’s Foundation Hosts Its First-Ever Medical Marijuana and Parkinson’s Disease Conference
Tuesday, December 4, 2018

NEW YORK AND MIAMI— December 4, 2018—The Parkinson’s Foundation will host its first-ever conference focused on medical marijuana and Parkinson’s disease (PD) in Denver, CO, March 6-7, 2019.

Parkinson's Foundation Hosts National Forum for Women Living with Parkinson's Disease
Wednesday, November 7, 2018

MIAMI & NEW YORK — NOVEMBER 7, 2018 —The Parkinson’s Foundation hosted the first national forum for women with Parkinson’s disease (PD) on October 19 at Baylor College of Medicine, a Parkinson’s Foundation Center of Excellence, in Houston, TX.

Parkinson’s Foundation Announces Expansion of Community Grants Program to Address Unmet Community Needs
Thursday, November 1, 2018

NEW YORK & MIAMI — November 1, 2018 — The Parkinson’s Foundation is proud to announce that it is requesting applications for community grants to be awarded nationwide for health, wellness and education programs that address unmet needs in the Parkinson’s disease (PD) community. In 2019, the Parkinson’s Foundation will award $1.2 million in community grants.

Parkinson’s Foundation Hosts Free Bilingual Caregiver Summit
Tuesday, October 30, 2018

MIAMI AND NEW YORK—October 30, 2018—The Parkinson’s Foundation will host a Caregiver Summit – “Cumbre Para Cuidadores” – geared specifically toward caregivers of people living with Parkinson’s disease (PD).

Parkinson’s Foundation Adds James Monhart to its Board of Directors
Monday, October 29, 2018

NEW YORK & MIAMI, October 29, 2018—The Parkinson’s Foundation today announced the election of James F.T. Monhart to its board of directors.

Pages

mail icon

Subscribe here to get the latest news on treatments, research and other updates.